Back to Treatments

Treatment

Hydralazine (IV)

1
Conditions
50
Trials
2,000
Participants
68%
Average Safety

Condition Evidence

Maternal hypertensive disorders

50 trials · 2,000 participants

85% effectiveness · 68% safety
Hydralazine (IV) | DFDA